Redx Pharma plc - Presentation of RXC007 Preclinical Efficacy Data

RNS Number: 0150 Z Redx Pharma plc 11 May 2023 REDX PHARMA PLC. Redx Presents Preclinical Efficacy Data for RXC007 Showing Significant Results in Cancer-Associated Fibrosis Models. Alderley Park, UK, 11 May 2023 Redx, the clinical-stage biotechnology company focused on discovering and developing novel, small molecule, targeted therapeutics for the...